167 related articles for article (PubMed ID: 37668560)
1. An Introduction to the North American Clinical Trials Network for Spinal Cord Injury Special Edition: Reflections on Accomplishments and a Look to the Future.
Fehlings MG; Neal CJ; Hejrati N; Harrop JS; Toups EG; Guest JD
J Neurotrauma; 2023 Sep; 40(17-18):1811-1816. PubMed ID: 37668560
[TBL] [Abstract][Full Text] [Related]
2. Riluzole in Spinal Cord Injury Study (RISCIS)-Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial.
Chow DS; Nguyen A; Park J; Wu L; Toups EG; Harrop JS; Guest JD; Schmitt KM; Aarabi B; Fehlings MG; Boakye M; Grossman RG
J Neurotrauma; 2023 Sep; 40(17-18):1889-1906. PubMed ID: 37130044
[TBL] [Abstract][Full Text] [Related]
3. North American Clinical Trials Network for the Treatment of Spinal Cord Injury: goals and progress.
Grossman RG; Toups EG; Frankowski RF; Burau KD; Howley S
J Neurosurg Spine; 2012 Sep; 17(1 Suppl):6-10. PubMed ID: 22985365
[TBL] [Abstract][Full Text] [Related]
4. History and Accomplishments of the North American Clinical Trials Network for Spinal Cord Injury, 2004-2022.
Tator CH; Guest JD; Neal CJ; Howley SP; Toups EG; Harrop JS; Aarabi B; Shaffrey CI; Fehlings MG
J Neurotrauma; 2023 Sep; 40(17-18):1823-1833. PubMed ID: 36515162
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial.
Fehlings MG; Moghaddamjou A; Harrop JS; Stanford R; Ball J; Aarabi B; Freeman BJC; Arnold PM; Guest JD; Kurpad SN; Schuster JM; Nassr A; Schmitt KM; Wilson JR; Brodke DS; Ahmad FU; Yee A; Ray WZ; Brooks NP; Wilson J; Chow DS; Toups EG; Kopjar B
J Neurotrauma; 2023 Sep; 40(17-18):1878-1888. PubMed ID: 37279301
[TBL] [Abstract][Full Text] [Related]
6. Interhospital Transfer Delays Care for Spinal Cord Injury Patients: A Report from the North American Clinical Trials Network for Spinal Cord Injury.
Kelly-Hedrick M; Ugiliweneza B; Toups EG; Jimsheleishvili G; Kurpad SN; Aarabi B; Harrop JS; Foster N; Goodwin RC; Shaffrey CI; Fehlings MG; Tator CH; Guest JD; Neal CJ; Abd-El-Barr MM; Williamson T
J Neurotrauma; 2023 Sep; 40(17-18):1928-1937. PubMed ID: 37014079
[No Abstract] [Full Text] [Related]
7. Trends in the Use of Corticosteroids in the Management of Acute Spinal Cord Injury in North American Clinical Trials Network Sites.
Hejrati N; Aarabi B; Neal CJ; Ugiliweneza B; Kurpad SN; Shaffrey CI; Guest JD; Toups EG; Harrop JS; Fehlings MG
J Neurotrauma; 2023 Sep; 40(17-18):1938-1947. PubMed ID: 36597351
[TBL] [Abstract][Full Text] [Related]
8. Variability in Early Surgery for Acute Cervical Spinal Cord Injury Patients: An Opportunity for Enhanced Care Delivery.
Neal CJ; Ugiliweneza B; Toups EG; Abd-El-Barr M; Jimsheleishvili G; Kurpad SN; Aarabi B; Harrop JS; Shaffrey CI; Fehlings MG; Tator CH; Grossman RG; Guest JD
J Neurotrauma; 2023 Sep; 40(17-18):1907-1917. PubMed ID: 37125447
[TBL] [Abstract][Full Text] [Related]
9. North American Clinical Trials Network for Spinal Cord Injury Registry: Methodology and Analysis.
Toups EG; Ugiliweneza B; Howley SP; Neal CJ; Harrop JS; Guest JD; Grossman RG; Fehlings MG
J Neurotrauma; 2023 Sep; 40(17-18):1817-1822. PubMed ID: 37125443
[TBL] [Abstract][Full Text] [Related]
10. A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury.
Grossman RG; Fehlings MG; Frankowski RF; Burau KD; Chow DS; Tator C; Teng A; Toups EG; Harrop JS; Aarabi B; Shaffrey CI; Johnson MM; Harkema SJ; Boakye M; Guest JD; Wilson JR
J Neurotrauma; 2014 Feb; 31(3):239-55. PubMed ID: 23859435
[TBL] [Abstract][Full Text] [Related]
11. Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN Phase I clinical trial.
Fehlings MG; Wilson JR; Frankowski RF; Toups EG; Aarabi B; Harrop JS; Shaffrey CI; Harkema SJ; Guest JD; Tator CH; Burau KD; Johnson MW; Grossman RG
J Neurosurg Spine; 2012 Sep; 17(1 Suppl):151-6. PubMed ID: 22985381
[TBL] [Abstract][Full Text] [Related]
12. Time is spine: a review of translational advances in spinal cord injury.
Badhiwala JH; Ahuja CS; Fehlings MG
J Neurosurg Spine; 2018 Dec; 30(1):1-18. PubMed ID: 30611186
[TBL] [Abstract][Full Text] [Related]
13. Importance of Prospective Registries and Clinical Research Networks in the Evolution of Spinal Cord Injury Care.
Kelly-Hedrik M; Abd-El-Barr MM; Aarabi B; Curt A; Howley SP; Harrop JS; Kirshblum S; Neal CJ; Noonan V; Park C; Ugiliweneza B; Tator C; Toups EG; Fehlings MG; Williamson T; Guest JD
J Neurotrauma; 2023 Sep; 40(17-18):1834-1848. PubMed ID: 36576020
[TBL] [Abstract][Full Text] [Related]
14. Natural history of neurological improvement following complete (AIS A) thoracic spinal cord injury across three registries to guide acute clinical trial design and interpretation.
Aimetti AA; Kirshblum S; Curt A; Mobley J; Grossman RG; Guest JD
Spinal Cord; 2019 Sep; 57(9):753-762. PubMed ID: 31182786
[TBL] [Abstract][Full Text] [Related]
15. Natural History, Predictors of Outcome, and Effects of Treatment in Thoracic Spinal Cord Injury: A Multi-Center Cohort Study from the North American Clinical Trials Network.
Wilson JR; Jaja BNR; Kwon BK; Guest JD; Harrop JS; Aarabi B; Shaffrey CI; Badhiwala JH; Toups EG; Grossman RG; Fehlings MG
J Neurotrauma; 2018 Nov; 35(21):2554-2560. PubMed ID: 29665733
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of riluzole in the treatment of spinal cord injury: a systematic review of the literature.
Srinivas S; Wali AR; Pham MH
Neurosurg Focus; 2019 Mar; 46(3):E6. PubMed ID: 30835675
[TBL] [Abstract][Full Text] [Related]
17. Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial.
Fehlings MG; Nakashima H; Nagoshi N; Chow DS; Grossman RG; Kopjar B
Spinal Cord; 2016 Jan; 54(1):8-15. PubMed ID: 26099215
[TBL] [Abstract][Full Text] [Related]
18. Predicting Recruitment Feasibility for Acute Spinal Cord Injury Clinical Trials in Canada Using National Registry Data.
Thibault-Halman G; Rivers CS; Bailey CS; Tsai EC; Drew B; Noonan VK; Fehlings MG; Dvorak MF; Kuerban D; Kwon BK; Christie SD
J Neurotrauma; 2017 Feb; 34(3):599-606. PubMed ID: 27627704
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of riluzole in acute spinal cord injury.
Chow DS; Teng Y; Toups EG; Aarabi B; Harrop JS; Shaffrey CI; Johnson MM; Boakye M; Frankowski RF; Fehlings MG; Grossman RG
J Neurosurg Spine; 2012 Sep; 17(1 Suppl):129-40. PubMed ID: 22985379
[TBL] [Abstract][Full Text] [Related]
20. Riluzole as a neuroprotective drug for spinal cord injury: from bench to bedside.
Nagoshi N; Nakashima H; Fehlings MG
Molecules; 2015 Apr; 20(5):7775-89. PubMed ID: 25939067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
